The Treatment of Hepatocirrhosis and Portal Hypertension
NCT02778425 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108
Last updated 2025-02-14
Summary
This study compare the efficiency of partial splenic embolization +endoscopical therapy with endoscopical therapy alone in gastroesophageal variceal haemorrhage accompanied with splenomegaly or hypersplenism of hepatocirrhosis and portal hypertension treatment.
Conditions
- Hepatic Cirrhosis
- Portal Hypertension
Interventions
- PROCEDURE
-
Endoscopic therapy+ beta blockers
Endoscopic variceal ligation (EVL) is for the secondary prophylaxis of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).A standard dose of NSBB (propranolol) was applied to patients according to the Baveno VI recommendations if there were no contraindications.
- PROCEDURE
-
Endoscopic therapy+ PSE+beta blockers
Endoscopic variceal ligation (EVL) is for the secondary prophylaxis of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).A standard dose of NSBB (propranolol) was applied to patients according to the Baveno VI recommendations if there were no contraindications.Partial splenic embolization (PSE) is one of the intra-arterial therapeutic approaches to embolize 60-80% splenic blood flow.
- PROCEDURE
-
beta blockers
A standard dose of NSBB (propranolol) was applied to the primary prevention patients according to the Baveno VI recommendations if there were no contraindications.
- PROCEDURE
-
Endoscopic therapy
Endoscopic variceal ligation (EVL) is for the primary prophylaxis of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).
- PROCEDURE
-
Endoscopic therapy+ PSE
Endoscopic variceal ligation (EVL) is for the primary prophylaxis of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).Partial splenic embolization (PSE) is one of the intra-arterial therapeutic approaches to embolize 60-80% splenic blood flow.
- PROCEDURE
-
Somatostatin+Endoscopic therapy
The first dose of 250 was injected intravenously, followed by a continuous iv infusion of 250 for 3-5 days. Endoscopic variceal ligation (EVL) is for the acute bleeding of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).
- PROCEDURE
-
Somatostatin+Endoscopic therapy+PSE
The first dose of 250 was injected intravenously, followed by a continuous iv infusion of 250 for 3-5 days. Endoscopic variceal ligation (EVL) is for the acute bleeding of esophageal variceal hemorrhage,and Cyanoacrylate injection is for gastric varices (GV).Partial splenic embolization (PSE) is one of the intra-arterial therapeutic approaches to embolize 60-80% splenic blood flow.
Sponsors & Collaborators
-
Shandong Provincial Hospital
collaborator OTHER_GOV -
Jinan Military General Hospital
collaborator OTHER -
Yanjing Gao
lead OTHER
Principal Investigators
-
Yanjing Gao Yanjing Gao, PhD.MD · Qilu Hospital,Shandong Universty
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2019-12-31
- Completion
- 2020-01-31
Countries
- China
Study Locations
More Related Trials
-
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
NCT02335580 ·Status: COMPLETED
-
Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy
NCT02505152 ·Status: UNKNOWN ·Phase: NA
-
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
NCT06122792 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCT
NCT02630095 ·Status: UNKNOWN ·Phase: PHASE4
-
ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis
NCT01560845 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices
NCT01426087 ·Status: UNKNOWN ·Phase: NA
-
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Gastrointestinal Bleeding and Acute Kidney Injury
NCT07252401 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
NCT02853526 ·Status: UNKNOWN ·Phase: PHASE3
-
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
NCT01326949 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Treatments for Cirrhosis With Varicose Veins
NCT06961474 ·Status: ACTIVE_NOT_RECRUITING
-
Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy
NCT02156232 ·Status: COMPLETED ·Phase: NA
-
HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)
NCT03783065 ·Status: UNKNOWN ·Phase: NA
-
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
NCT03130127 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial
NCT02178319 ·Status: UNKNOWN ·Phase: NA
-
TIPS for Platinum-Related Porto-Sinusoidal Vascular Disease With Variceal Bleeding
NCT06635122 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
NCT04221672 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis
NCT07253389 ·Status: RECRUITING ·Phase: NA
-
Splenic Embolization for Portal Hypertension
NCT03532750 ·Status: WITHDRAWN ·Phase: NA
-
Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding
NCT02377141 ·Status: COMPLETED ·Phase: NA
-
Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein
NCT02504034 ·Status: UNKNOWN ·Phase: NA
-
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol
NCT01298284 ·Status: UNKNOWN ·Phase: PHASE4
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
The Effect of Monitoring PVP on Clinical Outcomes in Patients With PH
NCT04820166 ·Status: RECRUITING
-
Endoscopic Ultrasound-guided Measurement of Portal Vein Pressure Gradient
NCT07062289 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS
NCT02925975 ·Status: UNKNOWN ·Phase: PHASE4